Strides Pharma Science gets USFDA EIR for Puducherry facility Ruchika Sharma19 May 2023 6:54 AM GMTBengaluru: Strides Pharma Science Limited has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA)...
Strides, Orbicular ink pact to develop range of nasal sprays Ruchika Sharma3 May 2023 6:00 AM GMTThe partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m.
Strides Pharma Science Bangalore facility gets USFDA inspection closure Ruchika Sharma24 Feb 2023 5:49 AM GMTThe flagship facility in Bangalore is the largest manufacturing facility for the company, with the capability to produce finished dosage formulation...
Strides Pharma Science successfully concludes WHO inspection at Puducherry facility Ruchika Sharma23 Jan 2023 8:45 AM GMTBengaluru: Strides Pharma Science Limited has announced that the company has successfully completed the inspection carried out by the World...
Strides Pharma Science Singapore arm secures USFDA okay for Potassium Chloride Oral Solution Ruchika Sharma18 Nov 2022 10:00 AM GMTPotassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for...
Strides Pharma reports net profit of Rs 33 lakh in Q2 Ruchika Sharma15 Nov 2022 5:45 AM GMTThe company's cost control measures have started yielding results and have enabled strong operating leverage during the quarter, Kumar said.
Strides Pharma Kenya based arm bags WHO certification to produce antimalarial drug Ruchika Sharma27 Aug 2022 6:17 AM GMTUniversal Corporation's pre-qualification was achieved with funding from global health agency Unitaid and support from MMV.
Board of Strides Pharma Science to consider fund raising through securities issuance Ruchika Sharma21 July 2022 7:45 AM GMTThe Bengaluru-based company did not share details of the amount proposed to be raised.
Strides Pharma recalls BP lowering drug Losartan Potassium in US over manufacturing issues Ruchika Sharma13 Jun 2022 5:15 AM GMTAs per the USFDA, the company has initiated the Class II recall due to "CGMP (current good manufacturing practices) deviations".
Strides Pharma Ibuprofen Oral Suspension gets USFDA okay Ruchika Sharma11 Jun 2022 6:15 AM GMTBengaluru: Strides Pharma Science Limited has recently announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited,...
Strides: Dr R Ananthanarayanan to depart as MD, Arun Kumar to take charge Ruchika Sharma30 March 2022 11:03 AM GMTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart ...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 3:30 AM GMTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
